DIA 2015 Annual Meeting, Washington, D.C. and Boston, Mass. – June 15, 2015 –BBK Worldwide, a leading clinical trial marketing firm, today announced My Research MateSM, a live streaming video app platform developed to educate consumers about cutting-edge treatment options and available clinical research studies, and the importance of clinical research more broadly. The app is intended to offer an enhanced experience through live video interactions with researchers, thought leaders, advocacy groups and even other patients and caregivers – of utmost importance to those struggling with rare and incurable diseases where research advances represent the only option for treatment.
Consumers continue to take the driver’s seat in their own health care and wellness, an evolving shift that will continue to impact clinical studies and help fuel mobile technology adoption across all areas of clinical research. What’s more, consumers increasingly prefer video over other forms of communication. It’s estimated that video will account for 74% of all internet traffic and 33% of tablet owners watch more than an hour of video on their device each day.
In support of these trends and underscoring BBK’s commitment to optimal patient engagement, My Research Mate was designed to leverage the power of video to help improve engagement and support more meaningful information sharing. The challenges that come with a diagnosis or managing illness are greatly compounded when patients and caregivers lack access to information, and this new offering was built to address that. My Research Mate also allows scientists and researchers to share research news, findings and related trial patient opportunities – and to do so directly and to the right audience.
“mHealth for clinical research continues to evolve quickly as we work as an industry to ensure that patients have greater access to study information – where, when and how they need it,” said Joan F. Bachenheimer, founding principal of BBK Worldwide. “Consider the newly diagnosed Alzheimer’s patient. While breakthrough science is advancing Alzheimer disease options, reaching those with early symptoms requires early intervention. It’s a very scary time, but it’s also the point at which patients and their caregivers could benefit greatly from information on the most advanced research options.”
“As mobile apps continue to become a bigger part of the clinical research and healthcare mix, patients will continue to rely on them to stay informed to help better manage their disease or condition – and we believe live streaming video is an important, natural next step,” continued Bachenheimer.
The new video platform will be available as a stand-alone tool and as a password-protected video feature within BBK’s mobile apps for patients and sites, My Clinical Study Buddy® and My Protocol PalSM respectively. For additional information, visit MyResearchMate.com, text “Innovate” to 31996 or email mhealth@bbkworldwide.com.
Visit BBK booth #2026 at the DIA Annual Meeting to learn more about the company’s software solutions and consulting services for improved patient recruitment and engagement.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Phase III Trial Data Show Subcutaneous Pembrolizumab as Noninferior to IV Keytruda
March 31st 2025Subcutaneous administration of pembrolizumab with chemotherapy demonstrated a nearly 50% reduction in patient chair and treatment room time while maintaining efficacy and safety endpoints compared to intravenous Keytruda.
Phase II ALPACA Trial Shows Lepodisiran Produces Significant, Sustained Lipoprotein(a) Reductions
March 31st 2025Eli Lilly’s lepodisiran, an investigational siRNA therapy, achieved significant and durable reductions in lipoprotein(a) levels, a major genetic risk factor for cardiovascular disease.